Brief: Atea Pharmaceuticals Appoints Howard H. Berman To Board Of Directors And Announces Share Repurchase Program
17/04/2025 12:05
April 17 (Reuters) - Atea Pharmaceuticals Inc AVIR.O: ATEA PHARMACEUTICALS APPOINTS HOWARD H. BERMAN TO BOARD OF DIRECTORS AND ANNOUNCES SHARE REPURCHASE PROGRAM ATEA PHARMACEUTICALS INC: AUTHORIZED REPURCHASE OF UP TO $25 MILLION OF COMPANY'S COMMON STOCK Source text: ID:nGNX7JPgR1 Further company coverage: AVIR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Coya Therapeutics
See all newsCoya Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Coya Therapeutics Q2 net loss widens as R&D costs rise
Coya Therapeutics Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: Coya Therapeutics Entered Into Sales Agreement, May Offer And Sell From Time To Time Shares Of Co's Common Stock For Up To $30 Million
Brief: Coya Therapeutics Has Been Granted U.S. FDA Fast Track Designation For Coya 302 For The Treatment Of Amyotrophic Lateral Sclerosis (ALS)